Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14
Approved uses and dosing context Across the class, FDA-approved indications include type 2 diabetes for most compounds, chronic weight management for Wegovy, Saxenda, and Zepbound, and obstructive sleep apnea in adults with obesity for Zepbound as of 2024
Funding was provided by Wellcome, the Medical Research Council, the European Union Horizon 2020 Program, the National Institutes of Health (grants U01-DK105535, U01-DK085545 and UM-1DK126185), the National Institute for Health Research Oxford Biomedical Research Centre, the Canadian Institutes of Health Research, the Novo Nordisk Foundation, Boehringer Ingelheim, and Diabetes Australia
Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography
The side effects of glutathione are the challenging factor for market growth
Mol Plant Pathol 21:3852
S-adenosyl methionine (SAMe)
US$ 29.50
US$ 28.26
US$ 24.21
US$ 29.17
US$ 22.35
US$ 22.66
US$ 25.71
